Patients with postacute sequelae of SARS-CoV-2 infection also have circulatory impairment, myalgic encephalomyelitis/chronic fatigue
Rates of COVID-19, Severe Illness Lower With BNT162b2 Booster Dose
Second study shows reduction in rate of death due to COVID-19 with booster dose of BNT162b2
Effectiveness of mRNA COVID-19 Vaccines Lower at ≥120 Days
Among U.S. veterans, VE was 86 percent for Moderna and 75 percent for PfizerBioNTech vaccines at ≥120 days after the second dose
FDA Approves Pfizer Boosters for Teens Aged 16 to 17
Pfizer first sought the approval for using the boosters in this age group at the end of November
200 Million Americans Are Now Fully Vaccinated as COVID-19 Cases Spike
White House officials noted that 12.5 million shots were given last week, the highest weekly total since May
FDA Approves Drug to Help Immunocompromised Fend Off COVID-19
One dose of Evusheld is administered as two separate, consecutive injections and may be effective for six months